Protecting patients and healthcare workers

© Greiner Bio-One GmbH

Sponsored • Safe blood collection products and value-based care

Protecting patients and healthcare workers

In the last decade, regional and global health organizations have pushed for making safety a central pillar of procurement, with a directive that cost should not be a barrier. The crucial question is: How easy is that to implement? How can a confident decision be reached that protects patients and healthcare workers without straining costs?

A Royal College of Nursing project reported that 100,000 needlestick accidents occur in the UK every year, and Bevan Brittan, a legal firm representing the NHS, estimates the cost of needlestick injuries (NSI) to each UK NHS trust to be around £ 500,000 each year in legal costs. And in the US, the initial treatment of a needlestick injury (NSI) can cost between US$ 800 - 6000 each, with initial costs of medication for the Hepatitis C virus starting at around US$ 25,000, and fines from OSHA beginning at US$ 13,260. It should be noted that this is before associated costs are taken into consideration; staff absence interrupts the efficiency of already heavily burdened departments, and reputational damage and morale pose a considerable challenge to a sector that is struggling with staff retention. 

The takeaway is that indirect costs exceed the direct costs. The EU and OSHA are rigorous in their safety directives with regards to NSI, and arriving at a decision in selecting a safety device that balances costs without sacrificing safety need not be a complicated process.

Which criteria should be used to evaluate a safety device?

An established culture of safety feeds into the selection process. But with a vast inventory of products available, how can this process be simplified? The decision should be based on the three pillars frontline healthcare worker input, ease of use and protecting patient safety and comfort.

How does a reliable supply chain support safety?

The culture of safety is in place, a short list of prospective manufacturers has been identified, fulfilling the code of conduct and sustainability criteria and the costs are clear. Should the cheapest option then be chosen? This is where a reliable supply chain can really add value in blood collection. Logistics have been transformed and optimized due to the pandemic, but still face a host of challenges; the costs of raw materials continue to increase and global events impact the availability and delivery of goods. So how does one manufacturer’s offering compare to a competitor’s?

Go with the safety flow


Source: Greiner Bio-One GmbH

The small details of blood collection kit matter in the lab, just as much as they do on the ward. It is why every detail of products and services from Greiner are designed with that safety approach in mind. From the moment a blood sample is drawn, to the moment it becomes data. 

Read the full article by scanning the code.


Read all latest stories

Related articles


Sponsored • Effects of the pandemic on patient care

Why safe blood collection is more important to nurses in 2023 than ever before

Being able to rely on a quality, safety-engineered device for blood collection allows staff to perform their tasks with the minimum of fuss. Nurse Constance Mak talks about the benefits of closed…


Video • Vacuette® Evoprotect Safety Blood Collection Set

The gentle touch: The next evolution of safety

Vacuette® Evoprotect is a user-friendly butterfly needle with an optimised design. The extra-thin walls have a positive effect on the flow rate and thus the duration of blood collection/infusion.


Video • The gentle touch

Vacuette® Evoprotect Safety Blood Collection Set: the next evolution of safety

Greiner Bio-One presents the Vacuette® Evoprotect Safety Blood Collection Set - the ideal choice for venous blood collection and short-term infusion of intervenous fluids.

Related products

Subscribe to Newsletter